643 related articles for article (PubMed ID: 18328449)
1. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice.
Lee HS; Han SY; Bae EA; Huh CS; Ahn YT; Lee JH; Kim DH
Int Immunopharmacol; 2008 Apr; 8(4):574-80. PubMed ID: 18328449
[TBL] [Abstract][Full Text] [Related]
2. Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice.
Nishitani Y; Tanoue T; Yamada K; Ishida T; Yoshida M; Azuma T; Mizuno M
Int Immunopharmacol; 2009 Nov; 9(12):1444-51. PubMed ID: 19733697
[TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycan degradation-inhibitory lactic acid bacteria ameliorate 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice.
Lee B; Lee JH; Lee HS; Bae EA; Huh CS; Ahn YT; Kim DH
J Microbiol Biotechnol; 2009 Jun; 19(6):616-21. PubMed ID: 19597321
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitis.
Fitzpatrick LR; Small J; Hoerr RA; Bostwick EF; Maines L; Koltun WA
Br J Nutr; 2008 Sep; 100(3):530-41. PubMed ID: 18279557
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis.
Kwon KH; Murakami A; Hayashi R; Ohigashi H
Biochem Biophys Res Commun; 2005 Nov; 337(2):647-54. PubMed ID: 16202978
[TBL] [Abstract][Full Text] [Related]
6. ZPDC glycoprotein inhibits inflammation-related cytokine and protein via nuclear factor-kappa B in dextran sulfate sodium-stimulated ICR mouse.
Lee SJ; Lim KT
Biomed Pharmacother; 2009 Aug; 63(7):528-36. PubMed ID: 18848762
[TBL] [Abstract][Full Text] [Related]
7. Combined effect of different lactic acid bacteria strains on the mode of cytokines pattern expression in human peripheral blood mononuclear cells.
Gackowska L; Michalkiewicz J; Krotkiewski M; Helmin-Basa A; Kubiszewska I; Dzierzanowska D
J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():13-21. PubMed ID: 17242484
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via the anti-inflammatory and immunomodulatory activities.
Liu YW; Su YW; Ong WK; Cheng TH; Tsai YC
Int Immunopharmacol; 2011 Dec; 11(12):2159-66. PubMed ID: 21996541
[TBL] [Abstract][Full Text] [Related]
9. Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice.
Sakata A; Ochiai T; Shimeno H; Hikishima S; Yokomatsu T; Shibuya S; Toda A; Eyanagi R; Soeda S
Immunology; 2007 Sep; 122(1):54-64. PubMed ID: 17451462
[TBL] [Abstract][Full Text] [Related]
10. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines.
Yasui Y; Hosokawa M; Mikami N; Miyashita K; Tanaka T
Chem Biol Interact; 2011 Aug; 193(1):79-87. PubMed ID: 21621527
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 2 monoclonal antibody or/and Toll-like receptor 4 monoclonal antibody increase counts of Lactobacilli and Bifidobacteria in dextran sulfate sodium-induced colitis in mice.
Dong L; Li J; Liu Y; Yue W; Luo X
J Gastroenterol Hepatol; 2012 Jan; 27(1):110-9. PubMed ID: 21722182
[TBL] [Abstract][Full Text] [Related]
12. Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics.
Frick JS; Fink K; Kahl F; Niemiec MJ; Quitadamo M; Schenk K; Autenrieth IB
Infect Immun; 2007 Jul; 75(7):3490-7. PubMed ID: 17485456
[TBL] [Abstract][Full Text] [Related]
13. [Expression and function of interleukin-18 in mouse dextran sulfate sodium colitis].
Wen ZH; Quyang Q; Zhang H; Yi ZH; Wang YF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):676-8. PubMed ID: 16235535
[TBL] [Abstract][Full Text] [Related]
14. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
Kwon KH; Murakami A; Tanaka T; Ohigashi H
Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
[TBL] [Abstract][Full Text] [Related]
15. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
16. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
[TBL] [Abstract][Full Text] [Related]
17. Dietary lactoferrin does not prevent dextran sulfate sodium induced murine intestinal lymphocyte death.
Spagnuolo PA; Hoffman-Goetz L
Exp Biol Med (Maywood); 2008 Sep; 233(9):1099-108. PubMed ID: 18535168
[TBL] [Abstract][Full Text] [Related]
18. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
[TBL] [Abstract][Full Text] [Related]
19. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.
Naito Y; Takagi T; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Yanagisawa R; Inoue K; Takano H; Satoh M; Yoshida N; Okanoue T; Yoshikawa T
Int J Mol Med; 2004 Aug; 14(2):191-6. PubMed ID: 15254764
[TBL] [Abstract][Full Text] [Related]
20. Carboxyamidotriazole ameliorates experimental colitis by inhibition of cytokine production, nuclear factor-κB activation, and colonic fibrosis.
Guo L; Ye C; Hao X; Zheng R; Ju R; Wu D; Luo L; Wang C; Li J; Yu X; Zhu L; Zhang D
J Pharmacol Exp Ther; 2012 Aug; 342(2):356-65. PubMed ID: 22553216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
